At Prince Biotech, we are pioneering the future of health care, specializing in immunotherapy and regenerative medicine through our groundbreaking discovery of Preimplantation Factor (PIF) and its synthetic analog, sPIF. Originally identified as a crucial biomolecule produced by a viable embryo during pregnancy, sPIF is now being developed to address some of the most urgent unmet needs in human health—ranging from autoimmune diseases and traumatic brain injury to acute radiation syndrome and stroke.

With a proven safety profile and over 50 scientific publications supporting its therapeutic potential, our mission is to transform lives by advancing sPIF from the embryo to healing. We are innovating in reproductive medicine with a novel IVF diagnostic test designed to improve pregnancy success rates.

Prince Biotech. From Embryo to Healing.